| 期刊全稱 | Antiangiogenic Agents in Cancer Therapy | | 影響因子2023 | Beverly A. Teicher,Lee M. Ellis | | 視頻video | http://file.papertrans.cn/159/158384/158384.mp4 | | 發(fā)行地址 | Current perspectives on state-of-the-art therapies.Contains chapters specific to angiogenesis and antiangiogenic treatment of many malignant diseases | | 學(xué)科分類 | Cancer Drug Discovery and Development | | 圖書封面 |  | | 影響因子 | .Antiangiogenesis remains a dynamic and evolving field in oncology. New therapeutic targets continue to emerge followed by the rapid development of new therapeutic agents to be investigated in clinical trials. Optimizing the therapeutic potential of antiangiogenic agents in combination with the other therapies in the armamentarium to fight cancer will be an on-going challenge. .Antiangiogenic Agents in Cancer Therapy, Second?Edition .provides a current, up-dated?perspective on the state of the art of angiogenesis and therapy with a compendium of scientific findings and approaches to the study of angiogenesis in cancer.? Leaders in the field present chapters on such topics as the environmental influences and the genetic and physiologic abnormalities that mediate angiogenesis and its role in the progression of malignant disease, working models of tumor angiogenesis,?and?the role of angiogenesis inhibition in the therapy of malignant disease in humans.?..Comprehensive and cutting-edge, .Antiangiogenic Agents in Cancer Therapy, Second?Edition.?is an ideal, valuable?guide to the most recent advances in the field, and a collection that will be?useful for many years to come.. | | Pindex | Book 2008Latest edition |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-13 10:24
發(fā)表于 2025-3-21 18:43:21
